News Release: July 28, 2025
4-Methylphenylsulfonylurea Price, Production, Latest News and Developments in 2025
The global market for 4-Methylphenylsulfonylurea has seen significant fluctuations in both pricing and production over the past five years, influenced by numerous factors such as raw material availability, energy costs, geopolitical developments, and regional demand shifts. For a comprehensive overview, readers can access the 4-Methylphenylsulfonylurea price trend and production News to understand the current dynamics shaping the market.
4-Methylphenylsulfonylurea Price Trend in Past Five Years and Factors Impacting Price Movements (2019–2024)
Between 2019 and 2024, the price of 4-Methylphenylsulfonylurea has experienced notable volatility, largely due to fluctuations in feedstock pricing, changes in regulatory frameworks, supply chain disruptions, and evolving end-user demand in pharmaceutical and agrochemical applications.
In 2019, the average global price for 4-Methylphenylsulfonylurea stood at approximately $3,500/MT. That year, the market remained relatively stable, with only slight regional differences in pricing based on production concentration and transport logistics. However, in 2020, the price surged to $3,900/MT as the COVID-19 pandemic disrupted chemical supply chains, leading to a scarcity of raw materials and reduced production in Asia and Europe.
By early 2021, some recovery was seen, but prices remained high at around $4,100/MT due to ongoing global shipping bottlenecks and high freight costs. With China’s chemical manufacturing hubs under temporary lockdowns, global dependence on Asian production became increasingly apparent. The situation was further intensified by energy shortages, which forced some producers to cut output, thereby reducing 4-Methylphenylsulfonylurea production capacity temporarily.
In 2022, stabilization efforts began to show results. Prices dropped slightly to around $3,800/MT as supply chains normalized, and production resumed in key manufacturing countries. However, the Russia-Ukraine conflict led to rising energy and transportation costs in Europe, causing European producers to scale back operations. This led to a partial price hike in the third quarter of the year, bringing average prices to approximately $4,000/MT again.
The year 2023 witnessed a more balanced trend. With increased domestic production in the United States and rising investments in alternative supply hubs in Southeast Asia, the price averaged $3,600/MT throughout the year. Technological improvements and strategic storage by leading producers helped mitigate the impact of raw material cost fluctuations.
Factors such as environmental regulations on sulfur-containing intermediates, changes in trade tariffs, and emerging demand from the pharmaceutical sector have consistently impacted 4-Methylphenylsulfonylurea price news. Additionally, seasonal variations in demand, particularly from agricultural industries using the compound in pesticide synthesis, have introduced periodic price shifts.
Looking ahead into 2025, market participants are cautiously optimistic about stability. However, the price is likely to remain sensitive to shifts in production capacities, especially in regions like China and India that hold major market shares. As of mid-2025, producers have increased their focus on vertical integration strategies and localized raw material sourcing to stabilize 4-Methylphenylsulfonylurea sales volume and pricing structure.
4-Methylphenylsulfonylurea Price Trend Quarterly Update in $/MT
The following are estimated quarterly prices for 4-Methylphenylsulfonylurea in 2025:
- Q1 2025: $3,750/MT
- Q2 2025: $3,680/MT
- Q3 2025: $3,720/MT
- Q4 2025: $3,800/MT
Quarterly movements in 2025 reflect moderate supply-demand balancing. The slight dip in Q2 was mainly due to increased domestic production in China and the arrival of new inventories in Southeast Asia, while the rebound in Q4 can be attributed to seasonal demand from the agricultural sector and tighter export regulations in the EU.
These price trends continue to influence procurement decisions across the supply chain, as well as the long-term planning strategies of downstream industries, including agrochemicals and pharmaceuticals.
Global 4-Methylphenylsulfonylurea Import-Export Business Overview
The international trade landscape for 4-Methylphenylsulfonylurea is evolving in line with changing global production dynamics and shifting end-user demands. Traditionally dominated by Asia-Pacific manufacturers, especially in China and India, the trade of 4-Methylphenylsulfonylurea is witnessing diversification as North America and parts of Europe ramp up domestic production capabilities.
In 2021, China accounted for nearly 45% of global 4-Methylphenylsulfonylurea exports, supplying mainly to Europe, South America, and Southeast Asia. However, concerns about over-reliance on a single country prompted various importing nations to explore alternative sources. India emerged as a growing exporter, increasing its share from 12% in 2021 to nearly 18% by 2024, thanks to government support for chemical sector exports and expanded production facilities.
Conversely, the United States and the European Union have traditionally been net importers of 4-Methylphenylsulfonylurea due to limited in-house production. However, recent years have seen a strategic shift. In 2023, the U.S. chemical industry announced the expansion of two new 4-Methylphenylsulfonylurea production plants in Texas and Louisiana, which began initial operations by mid-2024. This has led to a 9% reduction in imports for the U.S. market during the first half of 2025.
Similarly, the European market has shown increasing interest in localizing production. Germany and Belgium have initiated joint projects to explore sustainable production techniques for sulfonylurea derivatives, including 4-Methylphenylsulfonylurea. Though still at pilot stages, these projects aim to address environmental concerns while reducing dependency on imports.
Meanwhile, Southeast Asia continues to serve both as a supplier and a consumer. Countries such as Thailand and Vietnam have increased their 4-Methylphenylsulfonylurea imports in response to rising domestic use in the agrochemical sector. Exporters from China and India have leveraged free trade agreements to increase shipments to ASEAN nations, making the region an important hub for secondary formulation and distribution.
As of 2025, the top importers of 4-Methylphenylsulfonylurea include:
- Germany
- United States
- Brazil
- Vietnam
- South Korea
The top exporters are:
- China
- India
- Japan
- Singapore
- Netherlands
One of the key trends in 2025 is the growing influence of regulatory compliance in international trade. Exporters are now required to adhere to stricter documentation and quality assurance measures, especially for pharmaceutical-grade 4-Methylphenylsulfonylurea. This has led to consolidation among smaller exporters who are unable to meet the evolving regulatory frameworks in the U.S. and EU.
Digitalization of the supply chain is also becoming more prevalent. Several global logistics firms are now offering real-time tracking and traceability for chemical shipments, improving transparency and helping buyers better manage 4-Methylphenylsulfonylurea sales volume forecasts.
In terms of pricing impact, import-export duties continue to play a significant role. For instance, increased tariffs on Chinese chemicals in certain Western markets have driven price-sensitive buyers to seek alternative sources, indirectly affecting the 4-Methylphenylsulfonylurea price news globally.
Looking ahead, trade volumes are expected to remain stable, with marginal increases in 4-Methylphenylsulfonylurea production coming from newer manufacturing bases in Eastern Europe and South America. Brazil, in particular, is investing in downstream formulation facilities and may emerge as a notable importer of raw 4-Methylphenylsulfonylurea, exporting processed derivatives to neighboring countries.
The global import-export market will continue to be shaped by a combination of economic recovery trends, policy shifts in major markets, and the evolution of end-user industries. Companies across the supply chain are closely monitoring price fluctuations, policy changes, and shipping reliability to fine-tune procurement and sales strategies in 2025.
For more detailed analysis and sample data, visit the official report here:
4-Methylphenylsulfonylurea Production Trends by Geography
The global production landscape of 4-Methylphenylsulfonylurea has undergone considerable transformation over the last decade, especially with increasing demand from the pharmaceutical and agrochemical industries. As of 2025, production is geographically concentrated in a few key regions, with Asia-Pacific leading the charge, followed by North America and Europe. Regional policies, access to raw materials, labor cost dynamics, and environmental regulations have significantly shaped where and how 4-Methylphenylsulfonylurea is produced.
Asia-Pacific, particularly China and India, continues to dominate the production landscape. China remains the world’s largest producer of 4-Methylphenylsulfonylurea, accounting for over 40% of the global capacity. The country’s chemical manufacturing infrastructure, extensive supply chain networks, and government incentives have supported the growth of sulfonylurea-based chemical industries. In recent years, several large-scale facilities in provinces like Jiangsu and Zhejiang have been upgraded to meet international regulatory standards, improving both volume and quality of output. However, increasing pressure from environmental regulators has led to the closure or consolidation of several older facilities, pushing producers toward more sustainable and technologically advanced operations.
India has emerged as a strong secondary production hub. In 2025, India contributes nearly 25% to global 4-Methylphenylsulfonylurea production. Indian manufacturers have benefited from the global shift to diversify supply chains away from single-country dependence. Strategic alliances, process optimization, and export-oriented manufacturing policies have fueled the expansion of Indian facilities. States such as Gujarat and Maharashtra have become focal points for 4-Methylphenylsulfonylurea production due to easy access to raw materials and established chemical zones.
In North America, the United States has been making deliberate strides to boost domestic production. Rising concerns over supply chain risks, especially after the COVID-19 disruptions, have led to a policy-backed push to localize critical chemical manufacturing. By mid-2025, two newly established production plants in Texas and Louisiana are now fully operational. These facilities are contributing to about 12% of global 4-Methylphenylsulfonylurea output, with a strong emphasis on pharmaceutical-grade quality. Moreover, U.S. companies are integrating backward into raw material synthesis to gain cost control and supply security.
Europe’s contribution to global production is moderate but significant in terms of quality and regulatory compliance. Germany, Belgium, and the Netherlands are the main producers within the EU. European facilities are often geared toward producing high-purity 4-Methylphenylsulfonylurea for regulated pharmaceutical applications. Stringent environmental norms in the region have led to smaller batch sizes and slower expansion of capacity. Nonetheless, innovation in cleaner production technologies and automation has helped Europe maintain its niche position in the global market.
Other regions like Japan and South Korea have a limited but steady output, primarily for domestic consumption and high-value applications. These countries focus heavily on research-based production and are less impacted by the cost-centric dynamics that influence producers in Asia and North America.
Southeast Asia, particularly Thailand and Indonesia, is an emerging geography for 4-Methylphenylsulfonylurea manufacturing. These nations offer lower production costs and growing infrastructure. While still at a nascent stage, regional governments are showing interest in attracting foreign investments to set up specialty chemical units, including intermediates like 4-Methylphenylsulfonylurea.
Latin America, mainly Brazil, is entering the production space through contract manufacturing and downstream formulation. Brazil is expected to become a strategic player in regional supply by importing raw 4-Methylphenylsulfonylurea and converting it into formulated products for agriculture.
In summary, production is currently centered around Asia-Pacific, with increasing diversification toward North America and Europe. Regional variations in regulations, technology adoption, and market proximity will continue to define how the production trends evolve through 2025 and beyond.
4-Methylphenylsulfonylurea Market Segmentation
Market segmentation for 4-Methylphenylsulfonylurea typically includes the following segments:
- By Application
- Pharmaceuticals
- Agrochemicals
- Research & Development
- Industrial Chemicals
- By End-User Industry
- Pharmaceutical Companies
- Crop Protection and Agrochemical Companies
- Chemical Manufacturing Firms
- Research Institutions
- By Purity Grade
- Technical Grade
- Pharmaceutical Grade
- Laboratory Grade
- By Geography
- Asia-Pacific
- North America
- Europe
- Latin America
- Middle East & Africa
Explanation of Leading Segments
The most dominant segment in the 4-Methylphenylsulfonylurea market is pharmaceuticals, followed by agrochemicals. The compound’s sulfonylurea structure makes it a valuable intermediate in the synthesis of various pharmaceutical products, particularly in the development of anti-diabetic drugs. Demand in this segment is expected to grow steadily, supported by rising healthcare spending, increasing chronic disease prevalence, and expanding generic drug production. Pharmaceutical companies represent the largest consumer base due to the stringent requirements for purity and consistent quality.
Agrochemicals form the second-largest segment. The use of 4-Methylphenylsulfonylurea in the synthesis of herbicides and pesticides has seen a consistent rise, especially in regions with large agricultural output like India, China, and Brazil. The demand here is seasonal but high in volume, particularly during pre-planting and growth seasons. In this segment, technical-grade 4-Methylphenylsulfonylurea is more commonly used, offering a cost-effective solution for mass applications in crop protection.
The research and development segment, while smaller, plays a crucial role in pushing forward new applications. Academic and commercial research institutions use laboratory-grade 4-Methylphenylsulfonylurea for experimentation and new product development. This segment contributes to the innovation pipeline and often leads to the discovery of new applications, particularly in specialty chemicals and bioactives.
From a grade perspective, pharmaceutical grade leads in terms of value due to higher margins and regulatory requirements. This segment demands strict adherence to international quality norms and requires robust documentation. Manufacturers investing in high-purity 4-Methylphenylsulfonylurea production are also better positioned to form long-term contracts with pharmaceutical giants, ensuring stable revenue streams.
Technical grade dominates in volume terms because of its wide usage in agrochemical production. Cost efficiency and scalability make this grade the preferred choice for large-scale formulations. In this segment, consistency and stable pricing are more critical than ultra-high purity, allowing producers with medium-purity outputs to compete effectively.
By geography, Asia-Pacific is the leading market, both in terms of production and consumption. High agricultural activity and an expanding pharmaceutical manufacturing sector drive this dominance. India and China remain pivotal players due to strong domestic demand and export capabilities.
North America is another major market, particularly in pharmaceutical applications. The United States has increased its domestic consumption and production capacity in response to global supply uncertainties. Regulatory environments, however, can act as both a catalyst and a bottleneck depending on how swiftly approvals are granted.
Europe is growing steadily, particularly in the pharmaceutical segment. With a focus on sustainability and innovation, European players are investing in advanced manufacturing technologies and green chemistry initiatives.
Latin America, led by Brazil, is an emerging consumer of 4-Methylphenylsulfonylurea, driven largely by agricultural demand. The region is expected to witness increased demand for technical-grade product as agricultural reforms and modernization take root.
In conclusion, the 4-Methylphenylsulfonylurea market is highly segmented across applications, end-users, grades, and geographies. Pharmaceuticals and agrochemicals are the key application areas, while Asia-Pacific remains at the center of both supply and demand. The segmentation helps manufacturers align their production strategies with regional and sectoral requirements to ensure optimized supply chains and improved market reach.